Research & Development Programs

Naicons is dedicated to the discovery and characterization of bioactive compounds, in particular novel classes of antibiotics. Our research collaborations offer access to our technology platform and expertise to solve a client's need, like identifying drug leads, optimizing production processes, preparing a master cell bank, etc.

If your organization is interested in licensing an existing product or leveraging our platform through collaboration, get in touch.


Let's collaborate

Research & Development Programs

Naicons is dedicated to the discovery and characterization of bioactive compounds, in particular novel classes of antibiotics. Our research collaborations offer access to our technology platform and expertise to solve a client's need, like identifying drug leads, optimizing production processes, preparing a master cell bank, etc.

If your organization is interested in licensing an existing product or leveraging our platform through collaboration, get in touch.

Let's collaborate

Research collaborations

Our technology platform has the potential to discover drug leads well beyond the scope of our internal programs. To that end, we offer access to our strains, strain-derived products, data, and expertise to clients working in any sector and therapeutic area. We operate under a win-win business model in which access to the platform is provided essentially at cost, and, as the program advances, Naicons partakes in the client's success.

Our know-how and expertise can also be used to address a client's specific R&D needs, including screening, microbiology, chemistry, etc. We help clients design the best approach and can execute many of the steps in-house. Our extensive knowledge and experience in the area, together with our ability to work confidentially and respect timelines, can help you design, validate and execute your specific R&D objective.


Read about our collaborations

Proprietary programs

Naicons’ internal discovery programs focus on novel classes of antibacterial compounds discovered from our strain collection. These programs include derived assets, which are available for licensing, and earlier drug discovery programs.

Peruse our Early Development Programs and learn about our drug discovery program.

Research collaborations

Our technology platform has the potential to discover drug leads well beyond the scope of our internal programs. To that end, we offer access to our strains, strain-derived products, data, and expertise to clients working in any sector and therapeutic area. We operate under a win-win business model in which access to the platform is provided essentially at cost, and, as the program advances, Naicons partakes in the client's success.

Our know-how and expertise can also be used to address a client's specific R&D needs, including screening, microbiology, chemistry, etc. We help clients design the best approach and can execute many of the steps in-house. Our extensive knowledge and experience in the area, together with our ability to work confidentiality and respect timelines, can help you design, validate and execute your specific R&D objective.


Read about our collaborations

Proprietary programs

Naicons’ internal discovery programs focus on novel classes of antibacterial compounds discovered from our strain collection. These programs include derived assets, which are available for licensing, and earlier drug discovery programs.

Peruse our Early Development Programs and learn about our drug discovery program.

CONTACT US